Publicaciones en las que colabora con Angel L. Cogolludo Torralba (22)

2020

  1. Vitamin D deficiency downregulates TASK-1 channels and induces pulmonary vascular dysfunction

    American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 319, Núm. 4, pp. L627-L640

2018

  1. Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Activation of PPARβ/δ prevents hyperglycaemia-induced impairment of Kv7 channels and cAMP-mediated relaxation in rat coronary arteries

    Clinical Science, Vol. 130, Núm. 20, pp. 1823-1836

  2. Effects of quercetin in a rat model of hemorrhagic traumatic shock and reperfusion

    Molecules, Vol. 21, Núm. 12

2015

  1. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction

    Clinical Science, Vol. 129, Núm. 9, pp. 823-837

  2. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity

    Journal of Hypertension, Vol. 33, Núm. 9, pp. 1831-1844

  3. Kv7 channels critically determine coronary artery reactivity: Left-right differences and down-regulation by hyperglycaemia

    Cardiovascular Research, Vol. 106, Núm. 1, pp. 98-108

  4. Quercetin and its metabolites inhibit the membrane NADPH oxidase activity in vascular smooth muscle cells from normotensive and spontaneously hypertensive rats

    Food and Function, Vol. 6, Núm. 2, pp. 409-414

2014

  1. PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells

    British Journal of Pharmacology, Vol. 171, Núm. 12, pp. 3089-3102

  2. The flavonoid quercetin reverses pulmonary hypertension in rats

    PLoS ONE, Vol. 9, Núm. 12

2012

  1. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats

    Free Radical Biology and Medicine, Vol. 53, Núm. 4, pp. 730-741

2011

  1. Lack of synergistic interaction between quercetin and catechin in systemic and pulmonary vascular smooth muscle

    British Journal of Nutrition, Vol. 105, Núm. 9, pp. 1287-1293

2009

  1. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta

    Atherosclerosis, Vol. 204, Núm. 1, pp. 34-39

2008

  1. Flavonoids and cardiovascular disease: Mechanisms involved in the cardioprotective effects of quercetin

    Polyphenols and Health: New and Recent Advances (Nova Science Publishers, Inc.), pp. 1-30

  2. The HERACLES cardiovascular network

    Revista Espanola de Cardiologia, Vol. 61, Núm. 1, pp. 66-75

2007

  1. Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta

    Journal of Nutrition, Vol. 137, Núm. 4, pp. 910-915

2006

  1. Increased NADPH oxidase activity mediates spontaneous aortic tone in genetically hypertensive rats

    European Journal of Pharmacology, Vol. 544, Núm. 1-3, pp. 97-103

  2. The flavonoid quercetin induces apoptosis and inhibits JNK activation in intimal vascular smooth muscle cells

    Biochemical and Biophysical Research Communications, Vol. 346, Núm. 3, pp. 919-925

2004

  1. Nitric Oxide (NO) Scavenging and NO Protecting Effects of Quercetin and Their Biological Significance in Vascular Smooth Muscle

    Molecular Pharmacology, Vol. 65, Núm. 4, pp. 851-859

2003

  1. Effects of the Flavonoid Quercetin and its Methylated Metabolite Isorhamnetin in Isolated Arteries from Spontaneously Hypertensive Rats

    Planta Medica, Vol. 69, Núm. 11, pp. 995-1000